Catabolite repression control (Crc) gene and Pseudomonas virulence

ECU Author/Contributor (non-ECU co-authors, if there are any, appear on document)
David N. Collier (Creator)
Paul W. Hager (Creator)
Paul V. Phibbs (Creator)
East Carolina University (ECU )
Web Site:

Abstract: Extracted text; The present invention relates to a method of screening for compounds that inhibit the virulence of Pseudomonas bacteria and comprises the steps of: providing a culture medium comprising Pseudomonas bacteria, administering a test compound to said bacteria, and then detecting the presence or absence of inhibition of the catabolite repression control (Crc) protein in the bacteria. The inhibition of the Crc protein indicates that the compound has antivirulence activity against Pseudomonas bacteria. Antisense oligonucleotides that inhibit expression of the Crc protein in a Pseudomonas bacteria and is nuclease resistant are also disclosed. Antivirulence compounds and the uses thereof in treating Pseudomonas infections are also disclosed.

Additional Information

Language: English
Date: 2004

Email this document to

This item references:

TitleLocation & LinkType of Relationship
Catabolite repression control (Crc) gene and Pseudomonas virulence described resource references, cites, or otherwise points to the related resource.